Effect of fluidizing agents on paclitaxel penetration in cervical cancerous monolayer membranes

Journal of Membrane Biology

Volumn 219, Issue 1-3, 2007, Pages 83-91

  Preetha, A ^a   Huilgol, N ^b   Banerjee, R ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY BOMBAY   (India)

^b DR BALABHAI NANAVATI HOSPITAL   (India)

Author keywords

Cervical cancer; Drug penetration; Langmuir model membrane; Liposome; Paclitaxel

Indexed keywords

ANTINEOPLASTIC AGENT; DIOLEOYLPHOSPHATIDYLETHANOLAMINE; DIPALMITOYLPHOSPHATIDYLCHOLINE; LIPOSOME; PACLITAXEL; PHOSPHATIDYLGLYCEROL; PUMACTANT; SURFACTANT; TRITON X 100;

ARTICLE; BIOCOMPATIBILITY; CONTROLLED STUDY; DRUG ABSORPTION; DRUG FORMULATION; DRUG PENETRATION; FEMALE; HUMAN; HUMAN TISSUE; MONOLAYER CULTURE; SURFACE PROPERTY; UTERINE CERVIX CANCER;

1,2-DIPALMITOYLPHOSPHATIDYLCHOLINE; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA, SQUAMOUS CELL; CELL MEMBRANE PERMEABILITY; DRUG COMBINATIONS; FATTY ALCOHOLS; FEMALE; FLUORESCEINS; FLUORESCENT DYES; HUMANS; LIPOSOMES; MEMBRANE FLUIDITY; MEMBRANES, ARTIFICIAL; MODELS, BIOLOGICAL; PACLITAXEL; PHOSPHOLIPIDS; PHOSPHORYLCHOLINE; POLYETHYLENE GLYCOLS; SURFACE-ACTIVE AGENTS; UTERINE CERVICAL NEOPLASMS;

EID: 36649003044     PISSN: 00222631     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00232-007-9064-6     Document Type: Article

References (31)

1. Auner BG, O'Neill MAA, Valenta C, Hadgraft J (2005) Interaction of phloretin and 6-ketocholestanol with DPPC-liposomes as phospholipid model membranes. Int J Pharm 294:149-155
2. Banerjee R, Bellare JR (2001) Comparison of in vitro surface properties of clove oil-phospholipid suspensions with those of ALEC, Exosurf and Survanta. Pulm Pharmacol Ther 14:85-91
3. Bangham AD, Miller NGA, Davies RJ, Greendig LA, Morley CJ (1984) Introductory remarks about artificial lung expanding compounds (ALEC). Colloids Surf 10:337-341
4. Birdi KS (2003) Scanning Probe Microscopes: Applications in Science and Technology. Boca Raton, FL: CRC Press, pp 51-93
5. Brannon-Peppas L, Blanchette JO (2004) Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev 56:1649-1659
6. Crosasso P, Ceruti M, Brusa P, Arpicco S, Dosio F, Cattel L (2000) Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes. J Control Release 63:19-30
7. ®) from nanospheres of biodegradable polymers. J Control Release 71:53-69
8. Fidelio GD, Maggio B, Cumar FA (1986) Molecular parameters and physical state of neutral glycosphingolipids and gangliosides in monolayers at different temperatures. Biochim Biophys Acta 854:231-239
9. Fonseca C, Simoes S, Graspar R (2002) Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity. J Control Release 83:273-286
10. Gambinossi F, Mecheri B, Nocentini M, Puggelli M, Caminati G (2004) Effect of the phospholipid head group in antibiotic-phospholipid association at water-air interface. Biophys Chem 110:101-117
11. Kamagami S, Okabe H, Kainose H, Kikkawa M, Ishigami Y (1991) Penetration enhancement across a model membrane by liposomally entrapped drugs using N,N′-diacylcystine as a bilayer lipid. FEBS Lett 281:133-136
12. Kang L, Jun HW, McCall JW (2000) Physicochemical studies of lidocaine-menthol binary systems for enhanced membrane transport. Int J Pharm 206:35-42
13. Koziara JM, Lockman PR, Allen DD, Mumper RJ (2004) Paclitaxel nanoparticles for the potential treatment of brain tumors. J Control Release 99:259-269
14. ®. Int J Pharm 203:245-253
15. Park DC, Kim JH, Lew YO, Kim DH, Namkoong SE (2004) Phase II trial of neoadjuvant paclitaxel and cisplatin in uterine cervical cancer. Gynecol Oncol 92:59-63
16. Preetha A, Huilgol N, Banerjee R (2005a) Interfacial properties as biophysical markers of cervical cancer. Biomed Pharmacother 59:491-497
17. Preetha A, Banerjee R, Huilgol N (2005b) Surface activity, lipid profiles and their implications in cervical cancer. J Cancer Res Ther 1:180-186
18. Preetha A, Huilgol N, Banerjee R (2006) Comparison of paclitaxel penetration in normal and cancerous cervical model monolayer membranes. Colloids Surf B Biointerfaces 53:179-186
19. Ruan G, Feng S (2003) Preparation and characterization of poly (lactic acid)-poly (ethylene glycol)-poly(lactic acid) (PLA-PEG-PLA) microspheres for controlled release of paclitaxel. Biomaterials 24:5037-5044
20. Ruel-Gariepy E, Shive M, Bichara A, Berrada M, Garrec DL, Chenite A, Leroux J (2004) A thermosensitive chitosan-based hydrogel for the local delivery of paclitaxel. Eur J Pharm Biopharm 57:53-63
21. Savarrese A, Cognetti F (2003) New drugs in the treatment of recurrent or metastatic cervical cancer. Oncol Hematol 48:323-327
22. Simoes S, Moreira JN, Fonseca C, Duzgunes N, Pedroso-de-Lima MC (2004) On the formulation of pH-sensitive liposomes with long circulation times. Adv Drug Deliv Rev 56:947-965
23. Singla AK, Garg A, Aggarwal D (2002) Paclitaxel and its formulations. Int J Pharm 235:179-192
24. Takahashi A, Nemoto T, Fujiwara T (1994) Biophysical properties of protein-free, totally synthetic pulmonary surfactants, ALEC and Exosurf, in comparison with surfactant TA. Acta Paediatr Jpn 36:613-618
25. Vermehren C, Frokjaer S, Aurstad T, Hansen J (2006) Lung surfactant as a drug delivery system. Int J Pharm 307:89-92
26. Woolfson AD, Malcolm RK, Campbell K, Jones DS, Russell JA (2000) Rheological, mechanical and membrane penetration properties of novel dual drug systems for percutaneous delivery. J Control Release 67:395-408
27. II phase in the formation of a surface-active monolayer. Biochim Biophys Acta 776:37-47
28. Zhang JA, Anyarambhatla G, Ma L, Ugwu S, Xuan T, Sardone T, Ahmad I (2004) Development and characterization of a novel Cremphor EL free liposome-based paclitaxel (LEP-ETU) formulation. Eur J Pharm Biopharm 10:1-11
29. Zhao L, Feng S (2004) Effects of lipid chain length on molecular interactions between paclitaxel and phospholipid within model Biomembranes. J Colloid Interface Sci 274:55-68
30. Zhao L, Feng S (2005) Effects of lipid chain unsaturation and headgroup type on molecular interactions between paclitaxel and phospholipid within model biomembrane. J Colloid Interface Sci 285:326-335
31. Zhao L, Feng S (2006) Effects of cholesterol component on molecular interactions between paclitaxel and phospholipid within the lipid monolayer at the air-water interface. J Colloid Interface Sci 300:314-326